These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 22350116)

  • 21. Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularization: six-month results of a prospective pilot study.
    Chan WM; Lai TY; Liu DT; Lam DS
    Ophthalmology; 2007 Dec; 114(12):2190-6. PubMed ID: 17599414
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimation of visual outcome without treatment in patients with subfoveal choroidal neovascularization in pathologic myopia.
    Kojima A; Ohno-Matsui K; Teramukai S; Ishihara Y; Shimada N; Yoshida T; Sugamoto Y; Tokoro T; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 2006 Nov; 244(11):1474-9. PubMed ID: 16628418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optical coherence tomography to monitor photodynamic therapy in pathological myopia.
    García-Layana A; Salinas-Alamán A; Maldonado MJ; Sainz-Gómez C; Fernández-Hortelano A
    Br J Ophthalmol; 2006 May; 90(5):555-8. PubMed ID: 16464970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Choroidal neovascularization in pathologic myopia: three-year results after photodynamic therapy.
    Krebs I; Binder S; Stolba U; Glittenberg C; Brannath W; Goll A
    Am J Ophthalmol; 2005 Sep; 140(3):416-25. PubMed ID: 16139000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy of subfoveal choroidal neovascularization in high myopia in a clinical setting: visual outcome in relation to age at treatment.
    Axer-Siegel R; Ehrlich R; Weinberger D; Rosenblatt I; Shani L; Yassur Y; Priel E; Kramer M
    Am J Ophthalmol; 2004 Oct; 138(4):602-7. PubMed ID: 15488787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2 year follow up.
    Lam DS; Chan WM; Liu DT; Fan DS; Lai WW; Chong KK
    Br J Ophthalmol; 2004 Oct; 88(10):1315-9. PubMed ID: 15377558
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia.
    Ergun E; Heinzl H; Stur M
    Am J Ophthalmol; 2004 Sep; 138(3):434-8. PubMed ID: 15364227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics of patients with a favorable natural course of myopic choroidal neovascularization.
    Hayashi K; Ohno-Matsui K; Yoshida T; Kobayashi K; Kojima A; Shimada N; Yasuzumi K; Futagami S; Tokoro T; Mochizuki M
    Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):13-9. PubMed ID: 15290153
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patchy atrophy and lacquer cracks predispose to the development of choroidal neovascularisation in pathological myopia.
    Ohno-Matsui K; Yoshida T; Futagami S; Yasuzumi K; Shimada N; Kojima A; Tokoro T; Mochizuki M
    Br J Ophthalmol; 2003 May; 87(5):570-3. PubMed ID: 12714395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial--VIP report no. 3.
    Blinder KJ; Blumenkranz MS; Bressler NM; Bressler SB; Donato G; Lewis H; Lim JI; Menchini U; Miller JW; Mones JM; Potter MJ; Pournaras C; Reaves A; Rosenfeld P; Schachat AP; Schmidt-Erfurth U; Sickenberg M; Singerman LJ; Slakter JS; Strong HA; Virgili G; Williams GA
    Ophthalmology; 2003 Apr; 110(4):667-73. PubMed ID: 12689884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathologic myopia: where are we now?
    Tano Y
    Am J Ophthalmol; 2002 Nov; 134(5):645-60. PubMed ID: 12429239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients.
    Ruiz-Moreno JM; de la Vega C
    Br J Ophthalmol; 2001 Sep; 85(9):1041-3. PubMed ID: 11520751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.
    Verteporfin in Photodynamic Therapy Study Group
    Ophthalmology; 2001 May; 108(5):841-52. PubMed ID: 11320011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and risk factors for refractive errors in adult Chinese in Singapore.
    Wong TY; Foster PJ; Hee J; Ng TP; Tielsch JM; Chew SJ; Johnson GJ; Seah SK
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2486-94. PubMed ID: 10937558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subretinal surgery for choroidal neovascularization in patients with high myopia.
    Uemura A; Thomas MA
    Arch Ophthalmol; 2000 Mar; 118(3):344-50. PubMed ID: 10721956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visual acuity outcomes of patients 50 years of age and older with high myopia and untreated choroidal neovascularization.
    Tabandeh H; Flynn HW; Scott IU; Lewis ML; Rosenfeld PJ; Rodriguez F; Rodriguez A; Singerman LJ; Schiffman J
    Ophthalmology; 1999 Nov; 106(11):2063-7. PubMed ID: 10571338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heritability of myopic refractive errors in identical and fraternal twins.
    Angi MR; Clementi M; Sardei C; Piattelli E; Bisantis C
    Graefes Arch Clin Exp Ophthalmol; 1993 Oct; 231(10):580-5. PubMed ID: 8224933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractive status in the Beaver Dam Eye Study.
    Wang Q; Klein BE; Klein R; Moss SE
    Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4344-7. PubMed ID: 8002254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of myopia in the United States.
    Sperduto RD; Seigel D; Roberts J; Rowland M
    Arch Ophthalmol; 1983 Mar; 101(3):405-7. PubMed ID: 6830491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.